微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.49% | -34.03% | 40.16% | 77/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.49% | -14.43% | 33.16% | 72/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.87% | 16.15% | -70.69% | 64/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 6.38% | 7.05% | 20.6% | 51/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.29% | 4.55% | 81.79% | 66/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.91% | -1.36% | 80.75% | 70/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.61% | 53.33% | -72.99% | 70/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.96% | 11.82% | 17.79% | 68/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 5.06% | -0.39% | 71.53% | 63/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.95% | 2.08% | 180.95% | 71/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.05% | -3.67% | -80.3% | 89/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.33% | 33.25% | 4.92% | 78/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 5.08% | 106.5% | 75.78% | 80/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.89% | 110.95% | 165.14% | 84/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.09% | 1111.11% | -72.75% | 92/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4% | 98.02% | 62.6% | 94/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.46% | 101.64% | 79.56% | 92/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.37% | 128.33% | 1422.22% | 95/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.09% | -59.09% | -95.54% | 88/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.02% | 21.69% | 65.57% | 112/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 1.22% | -11.59% | 103.33% | 98/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.6% | -4.76% | 172.73% | 105/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.22% | 69.23% | -86.75% | 100/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 1.66% | -43.73% | 20.29% | 112/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.38% | -12.1% | 119.05% | 96/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 0.63% | 16.67% | 384.62% | 101/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.13% | -53.57% | -95.59% | 95/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.95% | 49.75% | 87.9% | 103/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.57% | 60.2% | 190.74% | 89/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.54% | 80% | 92.86% | 98/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.28% | 64.71% | -85.79% | 78/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 1.97% | 43.8% | 101.02% | 96/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.98% | -54.63% | 226.67% | 75/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 0.3% | -77.44% | 76.47% | 82/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.17% | -84.55% | -87.59% | 74/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 1.37% | -64.6% | -36.57% | 89/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.16% | -46.27% | 62.41% | 62/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 1.33% | -42.17% | 20.91% | 61/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.1% | -42.11% | -71.58% | 49/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |